Certive Solutions Inc. (CTVEF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -704.66 Thousand USD | 36.84% |
| 2022 | -1.64 Million USD | -54.83% |
| 2021 | -1.27 Million USD | 10.67% |
| 2020 | -757.65 Thousand USD | 27.46% |
| 2019 | -267.17 Thousand USD | 14.39% |
| 2018 | -4.38 Million USD | 29.77% |
| 2017 | -3.34 Million USD | 28.14% |
| 2016 | -5.01 Million USD | -176.55% |
| 2015 | -1.83 Million USD | -14.5% |
| 2014 | -1.58 Million USD | -82.2% |
| 2013 | - USD | -30.19% |
| 2012 | -667.69 Thousand USD | -380.18% |
| 2011 | -139.05 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -172.77 Thousand USD | 33.5% |
| 2024 Q1 | -194.41 Thousand USD | 33.99% |
| 2024 Q2 | -278.73 Thousand USD | -27.12% |
| 2023 Q1 | -451 Thousand USD | 44.5% |
| 2023 Q2 | -335.94 Thousand USD | 25.51% |
| 2023 FY | - USD | 36.84% |
| 2023 Q3 | -268.73 Thousand USD | 20.01% |
| 2023 Q4 | -329.71 Thousand USD | -22.69% |
| 2022 Q1 | -477.6 Thousand USD | -20.78% |
| 2022 FY | - USD | -54.83% |
| 2022 Q4 | -812.69 Thousand USD | -63.49% |
| 2022 Q3 | -497.1 Thousand USD | -32.39% |
| 2022 Q2 | -375.49 Thousand USD | 21.38% |
| 2021 Q2 | -286.64 Thousand USD | -22.81% |
| 2021 FY | - USD | 10.67% |
| 2021 Q1 | -233.39 Thousand USD | -26.33% |
| 2021 Q4 | -395.42 Thousand USD | -31.54% |
| 2021 Q3 | -300.62 Thousand USD | -4.88% |
| 2020 Q3 | -555.91 Thousand USD | -80.66% |
| 2020 Q2 | -307.72 Thousand USD | 24.42% |
| 2020 FY | - USD | 27.46% |
| 2020 Q4 | -184.75 Thousand USD | 66.77% |
| 2020 Q1 | -407.14 Thousand USD | 49.69% |
| 2019 Q3 | -590.76 Thousand USD | -60.31% |
| 2019 FY | - USD | 14.39% |
| 2019 Q1 | -448.82 Thousand USD | 41.79% |
| 2019 Q2 | -368.5 Thousand USD | 17.9% |
| 2019 Q4 | -809.32 Thousand USD | -37.0% |
| 2018 Q2 | -736.78 Thousand USD | -10.38% |
| 2018 FY | - USD | 29.77% |
| 2018 Q4 | -770.99 Thousand USD | -2.87% |
| 2018 Q3 | -749.46 Thousand USD | -1.72% |
| 2018 Q1 | -667.49 Thousand USD | 66.6% |
| 2017 FY | - USD | 28.14% |
| 2017 Q1 | -319.38 Thousand USD | 88.77% |
| 2017 Q2 | -1.07 Million USD | -236.05% |
| 2017 Q3 | -664.73 Thousand USD | 38.07% |
| 2017 Q4 | -1.99 Million USD | -200.66% |
| 2016 Q1 | -320.76 Thousand USD | 59.8% |
| 2016 FY | - USD | -176.55% |
| 2016 Q4 | -2.84 Million USD | -216.25% |
| 2016 Q3 | -898.91 Thousand USD | 32.79% |
| 2016 Q2 | -1.33 Million USD | -316.98% |
| 2015 Q1 | -45.02 Thousand USD | 90.32% |
| 2015 Q4 | -797.99 Thousand USD | -40.84% |
| 2015 Q3 | -566.58 Thousand USD | -40.3% |
| 2015 Q2 | -403.83 Thousand USD | -796.86% |
| 2015 FY | - USD | -14.5% |
| 2014 Q2 | -240.6 Thousand USD | 48.43% |
| 2014 Q4 | -465.25 Thousand USD | -11.1% |
| 2014 FY | - USD | -82.2% |
| 2014 Q3 | -418.77 Thousand USD | -74.05% |
| 2014 Q1 | -466.6 Thousand USD | -2996.81% |
| 2013 Q3 | -140.28 Thousand USD | 64.27% |
| 2013 Q4 | -15.06 Thousand USD | 89.26% |
| 2013 FY | - USD | -30.19% |
| 2013 Q2 | -392.67 Thousand USD | 10.75% |
| 2013 Q1 | -439.97 Thousand USD | 31.14% |
| 2012 Q2 | -8465.04 USD | -49.4% |
| 2012 Q4 | -638.98 Thousand USD | -7168.02% |
| 2012 FY | - USD | -380.18% |
| 2012 Q1 | -5666.00 USD | 95.17% |
| 2012 Q3 | -8791.73 USD | -3.86% |
| 2011 Q3 | -2827.20 USD | 84.42% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | -18.14 Thousand USD | 0.0% |
| 2011 Q4 | -117.3 Thousand USD | -4049.22% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 91.536% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -2.84 Million USD | 75.243% |
| Cannabis Sativa, Inc. | -1.11 Million USD | 36.775% |
| CompuMed, Inc. | 690.19 Thousand USD | 202.097% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.331% |
| Cogstate Limited | 9.89 Million USD | 107.124% |
| CareView Communications, Inc. | -210.04 Thousand USD | -235.489% |
| Craneware plc | 54.26 Million USD | 101.299% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 94.268% |
| Drug Free Solution, Inc. | -1.39 Million USD | 49.484% |
| DATATRAK International, Inc. | 2.72 Million USD | 125.826% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -974.019% |
| Healixa Inc. | -6.32 Million USD | 88.851% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 106.93% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -65.613% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | - USD | Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | -90.268% |
| Cannabiz Mobile, Inc. | -750.00 USD | -93855.2% |
| Mednow Inc. | -28.12 Million USD | 97.494% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | -160.29% |
| MediXall Group, Inc. | -6.52 Million USD | 89.198% |
| Mitesco, Inc. | -11.96 Million USD | 94.11% |
| MobileSmith, Inc. | -13.83 Million USD | 94.908% |
| NantHealth, Inc. | -38.53 Million USD | 98.171% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 58.5% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.08 Million USD | 94.17% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 94.176% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 153.72% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 1042.947% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -5683.519% |
| Renalytix Plc | -28.52 Million USD | 97.529% |
| Revium Recovery Inc. | -678 Thousand USD | -3.933% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -369.00 USD | -190865.854% |
| Vaso Corporation | 4.19 Million USD | 116.798% |
| Vynleads, Inc. | -235.72 Thousand USD | -198.934% |